Wave Life Sciences (WVE) Accounts Payables (2016 - 2025)
Historic Accounts Payables for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $14.5 million.
- Wave Life Sciences' Accounts Payables rose 1337.14% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 1337.14%. This contributed to the annual value of $16.3 million for FY2024, which is 2666.1% up from last year.
- Per Wave Life Sciences' latest filing, its Accounts Payables stood at $14.5 million for Q3 2025, which was up 1337.14% from $14.7 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Accounts Payables ranged from a high of $18.1 million in Q2 2024 and a low of $7.3 million during Q4 2021
- For the 5-year period, Wave Life Sciences' Accounts Payables averaged around $12.8 million, with its median value being $12.8 million (2024).
- As far as peak fluctuations go, Wave Life Sciences' Accounts Payables tumbled by 4722.0% in 2021, and later soared by 13231.7% in 2022.
- Over the past 5 years, Wave Life Sciences' Accounts Payables (Quarter) stood at $7.3 million in 2021, then surged by 132.32% to $16.9 million in 2022, then dropped by 24.1% to $12.8 million in 2023, then increased by 26.66% to $16.3 million in 2024, then dropped by 10.9% to $14.5 million in 2025.
- Its last three reported values are $14.5 million in Q3 2025, $14.7 million for Q2 2025, and $14.4 million during Q1 2025.